Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis - Ng, B; Dong, J; D'Agostino, G; Viswanathan, S; Widjaja, AA; Lim, W-W; Ko, NSJ; Tan, J; Chothani, SP; Huang, B; Xie, C; Pua, CJ; et al. (Science Translational Medicine, 2019)